Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

INTRODUCING URBANISTA LONDON: SOUND AND SILENCE

Silence the outside world or let the sound in with Urbanista’s new active noise cancelling earphonesFor immediate release: 6[th] May 2020, Stockholm, Sweden – Urbanista, the Swedish lifestyle audio brand, announces the launch of Urbanista London, an active noise cancelling true wireless earphone, designed to put the listener in control. London is the latest in the brand’s true wireless headphone line-up and lives up to their tagline: ‘Designed for Life in Motion’. Boasting an in-ear style that combines secure fit and crystal clear, isolated sound with comfort, simplicity and reliability,

NATTO : INITIAL RESPONSE TO OFFERS BY KAPPA BIOSCIENCE

Oslo, Norway (29 May 2020) — Reference is made to the stock exchange notice issued on 28 May 2020 regarding an announcement of offers by Kappa Bioscience AS ("Kappa") to acquire shares in Nattopharma ASA ("NattoPharma" or the "Company") at an offer price per share of NOK 12.75 (the "Offer Price") through; (i) a contemplated voluntary offer for all shares of the Company (the "Voluntary Offer"), and (ii) an unconditional offer to acquire up 2,127,573 shares in the Company (the "Offer"). The Board of Directors of NattoPharma (the "Board") is in the process of engaging a financial advisor to

15% energy cost savings and improved indoor climate with IoT and AI

Talkpool and Myrspoven jointly deliver Smart Building solutions for energy savings and improved air quality to prime real estate companies. Results from the first commercial installations show energy savings of 10-20% AND much improved indoor climate. Hence the smart building solution improves health and wellbeing while reducing energy costs. The wireless solution with battery-powered sensors is easy to install in all kinds of buildings. Talkpool provides sensors, connectivity, data management and services. The indoor climate is monitored in real-time with Talkpool’s OY1210 LoRaWAN CO2

Cinkciarz.pl wins with Mastercard in the EU Court in 12 trademark matters

The Court of the European Union in Luxembourg agreed with Cinkciarz.pl in 12 proceedings initiated by Mastercard International, Inc. before the European Union Intellectual Property Office (EUIPO).In 2016, Mastercard filed 12 oppositions against Cinkciarz.pl trademarks comprising elements of two overlapping circles claiming that they fall within the monopoly of Mastercard trademarks.  The EUIPO at first instance agreed with Cinkciarz.pl and dismissed the oppositions on the grounds that the trademarks are not similar, but the Board of Appeals of EUIPO overruled these decisions. According

Alligator Bioscience presents novel supportive Phase I data at ASCO for its CTLA-4 x OX40 bispecific drug candidate ATOR-1015

Lund, Sweden, May 29, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX), announces that the company today presents additional novel data from the ongoing Phase I clinical trial with the bispecific drug candidate ATOR-1015 developed as tumor-directed therapy for metastatic cancer, which further validates the potential of the drug. The presentation will be held at the ASCO (American Society of Clinical Oncology) Annual Meeting, which this year is being held virtually. The results from the evaluation of doses up and including 600 mg (about 10 mg/kg) show that ATOR-1015 is well tolerated,

Enhertu significantly improved tumour response rate and overall survival in HER2-positive metastatic gastric cancer in Phase II DESTINY-Gastric01 trial

29 May 2020 13:00 BST Enhertu significantly improved tumour response rate and overall survival in HER2-positive metastatic gastric cancer in Phase II DESTINY-Gastric01 trial First HER2-directed medicine to show an improvement in overall survival for previously treated metastatic gastric cancer with a 41% reduction in the risk of death vs. chemotherapy Breakthrough Therapy Designation recently granted in the USfor Enhertu in this setting Detailed results from the positive, registrational, randomised controlled Phase II DESTINY-Gastric01 trial showed AstraZeneca and Daiichi

Imfinzi showed a sustained overall survival benefit in 1st-line extensive-stage small cell lung cancer in the Phase III CASPIAN trial

29 May 2020 13:00 BST Imfinzi showed a sustained overall survival benefit in 1st-lineextensive-stage small cell lung cancer in the Phase III CASPIAN trial ASCO data show more than 10% of patients on Imfinzi plus chemotherapy had not progressed and remained on treatment at two years vs. 2.9% on chemotherapy alone Detailed results from an updated analysis of the Phase III CASPIAN trial showed AstraZeneca's Imfinzi (durvalumab) in combination with a choice of chemotherapies, etoposide plus either carboplatin or cisplatin, demonstrated a sustained, clinically meaningful overall

Interim Report 30[th] December 2019 to 29 March 2020

FRIDAY, 29[th] MAY, 14:00 CETJANUARY to MARCH 2020 · Net sales amounted to £28.3 million · EBITDA before special items amounted to £5,421k up 32.2% on the same quarter last year · Operating profit amounted to £3,881k · Profit before tax amounted to £854k · Cash and cash equivalents at the end of the period were £21,965k  Q2 revenues were 4.5% ahead of the same quarter last year despite the negative impact on the closure of the business on 24[th] March, one week before the end of the quarter. Continued rigorous cost control, reduction in media spend due to the COVID 19

Bondholder meetings

Reference is made to the stock exchange notice on 14 May 2020 in which it was advised that bondholder meetings were summoned for 29 May 2020 for the SOFF 04 (ISIN NO 0010713548) and the Solship Invest 1 AS bond issues (ISIN 0010779945). The proposed decisions in the summons dated 14 May 2020 were approved in both bondholder meetings today. ContactsLars Peder Solstad CEO, at +47 91 31 85 85Anders Hall Jomaas CFO, at +47 40 04 29 18 Skudeneshavn, May 29[th], 2020Solstad Offshore ASA This information is subject of the disclosure requirements according to the Norwegian

Extended cooperation with UPM in Pietarsaari

BillerudKorsnäs and UPM have entered into an agreement that will extend the supply agreement for pulp, steam and electricity for the production at BillerudKorsnäs’ mill in Pietarsaari.The original agreement was signed in 2012 in conjunction with BillerudKorsnäs’ acquisition of the Pietarsaari mill and was initially scheduled to expire in June 2022. The now agreed new supply contract is based on market conditions and will enter into force in June 2020. As part of the renegotiation, the parties have agreed that BillerudKorsnäs will pay a compensation of EUR 15 million to UPM during the coming

Share capital and total number of voting rights ultimo May 2020

Vestas Wind Systems A/S, Aarhus, 29 May 2020Company announcement No. 21/2020   Share capital and total number of voting rights ultimo May 2020 As announced on 6 May 2020, Vestas Wind Systems A/S has completed a capital reduction of nominally DKK 1,977,848 representing 1,977,848 shares of nominally DKK 1 each in connection with cancellation of treasury shares. In accordance with section 32 of the Danish Capital Markets Act, Vestas Wind Systems A/S is required to disclose the total number of voting rights and the size of the share capital in the company no later than at the end

New number of votes in AB Volvo

The number of votes in AB Volvo has changed due to the conversion of a total of 526 607 Series A shares to a total of 526 607 Series B shares. The conversions were implemented with the support of the opportunity for Series A shareholders to request conversion of Series A shares to Series B shares which was entered in the Articles of Association at the 2011 Annual General Meeting.Today, May 29, 2020, the last trading day of the month, there are a total of 2,128,420,220 registered shares in AB Volvo. Of these are 475,883,804 Series A shares and 1,652,536,416 Series B shares. The number of

Cabonline publish Interim report for the period January to March 2020

JANUARY-MARCH · Revenue amounted to MSEK 1,410 (1,499), a decrease of 6%. Organically, revenue fell 13.8%. · Adjusted EBITA was MSEK 44 (61) and the corresponding margin was 3.1% (4.1). · Operating profit amounted to MSEK -10 (9) including items affecting comparability of MSEK -19 (-20). · Net loss for the period was MSEK -49 (-11). · Earnings per share before and after dilution were SEK -1.73 (-0.66). · Cash flow for the period was MSEK -37 (-9).OUTLOOK AND EVENTS AFTER THE REPORTING PERIOD · Cabonline Group, and its transporters, have seen a clear decrease of taxi

Tim Hortons U.K. & Ireland Reopening City Centre locations

Tim Hortons[®], the iconic Canadian coffee chain, has announced that it will reopen four more restaurants following the successful trial of seven Drive Thru restaurants earlier this month. The restaurants, all in city centre locations, will be open for takeaway and delivery only in partnership with Deliveroo and Just Eat. Customers will be allowed to enter the restaurant, place an order, and collect their food and beverages. There will be no dine-in option available to customers. East Gates, Leicester will be the first to open on Saturday 30 May, followed by New Street, Birmingham,

Össur hf: Össur’s total share capital

Announcement no. 29/2020 29 May 2020  Össur’s total share capital According to Article 84 of the Icelandic Act on Securities Transactions no. 108/2007, an issuer shall publish information on its total share capital on the last trading day of the month when the share capital has been decreased. Össur’s total share capital is ISK 423,000,000 nominal value divided into the same number of shares with a nominal value of ISK 1 each following the share capital decrease. For further information, see the Company’s announcement no. 28/2020 published on 28 May 2020. Further information

Lundbergs Interim report January – March 2020

· On March 31, 2020, net asset value after deferred tax amounted to SEK 85.9 billion (SEK 346 per share), compared with SEK 96.3 billion (SEK 388 per share) on December 31, 2019. The corresponding values on May 27, 2020 were SEK 92.1 billion (SEK 371 per share).  · Consolidated net sales amounted to SEK 5.414 billion (5,615).  · Profit after financial items amounted to SEK -2,750 m. (4,902) where earnings from participations in associated companies amounted to SEK -2,982 m. (2,688). Profit after financial items excluding unrealized changes in value amounted to SEK -2,096 m. (4,093)

Industrial Solar Holding Europe AB: Summary Interim Report Q1/2020

Summary of the 1st quarter report1st Quarter from 01.01.2020 to 31.03.2020 (01.01.2019 – 31.03.2019) · The company´s sales amounted to 577 (421) TSEK · Increase in finished goods, inventories and work in progress 0 (0) TSEK · Other operating income 472 (44) TSEK · Total Income 1.049 (465) TSEK · Cost of Material 192 (372) TSEK · Personnel costs 1.359 (1.570) TSEK · Other operating costs 731 (654) TSEK · Depreciation 49 (31) TSEK · Total Costs 2.331 (2.627) TSEK · Earnings before interest and taxes -1.282 (-2.162) TSEK · Financial income/expenses -3 (0)

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

Lund, Sweden, 12:00 pm CET, 29 May 2020 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today announced a change in the number of shares and votes. During May, the number of shares and votes in BONESUPPORT HOLDING AB (publ) has increased with 10,500,000 due to the directed share issue as communicated on 26 May 2020. As of 31 May 2020, the number of shares in BONESUPPORT HOLDING AB (publ) amounts to 64,388,740 shares, of which 63,153,740 are ordinary shares with one vote per share and 1,235,000 are series C shares with one-tenth

BioStock: Iconovo in collaboration with Malmö University

Iconovo’s expertise in developing inhalers and inhalation platforms for treating respiratory diseases has been key to generating several important collaborations. The latest comes in the form of a research partnership with Biofilms – Research Center for Biointerfaces at Malmö University and Swedish biotech Nanologica to develop an inhalation platform based on porous drug carriers. The collaboration could result in a breakthrough in inhalation therapy.Read the full article at biostock.se: https://www.biostock.se/en/iconovo-in-collaboration-with-malmo-university/ This is a press release

Vestas wins 38 MW order in the UK

News release from Vestas Northern and Central EuropeHamburg, 29 May 2020 Vestas has secured a 38 MW project in the UK that will be located in the southwestern part of Scotland. The wind park will feature a customised Vestas solution, including nine V117-4.2 MW turbines with 81.5 m towers to maximise energy production in the site’s medium to high wind conditions while meeting the tip height requirements. “This project enables a highly competitive business case for our customer and offers the lowest cost of energy to the British energy consumers. It marks another step forward for

NoHo Partners Plc has completed the financing arrangements for the duration of the exceptional situation

NoHo Partners Plc STOCK EXCHANGE RELEASE 29 May 2020 at 12:30 NoHo Partners Plc has completed the financing arrangements for the duration of the exceptional situation NoHo Partners previously announced a financing package of EUR 34 million for the duration of the exceptional coronavirus pandemic situation. The company has now also finalised its refinancing programme for its maturing debt as part of its overall financing package. As the final part of the financing package, the company has agreed on a debt of EUR 10 million with a right to conversion with the Finnish Industry

There are no items matching the current filter
There are no more items matching the current filter
Back to top